|
Symbol Name ID |
Amacr
alpha-methylacyl-CoA racemase MGI:1098273 |
| Darker colors indicate more annotations |
| Human Phenotypes | Hyperbilirubinemia |
Decreased serum bile acid concentration |
Elevated circulating phytanic acid concentration |
Increased phytanic acid:pristanic acid ratio |
Increased circulating very long-chain fatty acid concentration |
Elevated circulating creatine kinase concentration |
Abnormal circulating enzyme concentration or activity |
Elevated circulating hepatic transaminase concentration |
Elevated circulating aspartate aminotransferase concentration |
Reduced alpha-methylacyl-CoA racemase activity in cultured fibroblasts |
Type II diabetes mellitus |
Decreased circulating vitamin E concentration |
Decreased circulating calcifediol concentration |
Decreased circulating vitamin K concentration |
| Disease(s) Associated with AMACR | ||||||||||||||
| alpha-methylacyl-CoA racemase deficiency | ||||||||||||||
| congenital bile acid synthesis defect 4 |
| Mouse Phenotypes | abnormal circulating cholesterol level |
increased circulating alkaline phosphatase level |
decreased fatty acids level |
increased fatty acids level |
decreased triglyceride level |
|
| Availability | Mouse Genotype | |||||
| Amacrtm1Jkh/Amacrtm1Jkh | ||||||
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/09/2024 MGI 6.23 |
|
|
|
||
Analysis Tools